Hematologic Malignancies Research
Hematologic malignancies including leukemia are forms of cancer that begin in the immature white cells of blood-forming tissues including bone marrow and the immune system. Researchers at the Center for Childhood Cancer Research are using state-of-the art genomic, immunotherapeutic and targeted molecular approaches to develop new therapies to treat pediatric leukemias and related hematologic malignancies.
New Developments in Precision Medicine Therapy for Children with Acute Lymphoblastic Leukemia
The Children’s Oncology Group (COG) high risk acute lymphoblastic leukemia (HR ALL) TARGET Project is a large collaborative effort led by Stephen Hunger, MD.